HOME
ABOUT US
STRATEGY
TEAM
PORTFOLIO
4BATLE ICAV
NEWSROOM
CONTACT
More
EGLSF I wins two EuroHedge Emerging Fund Management Awards
4BIO portfolio company Orchard Therapeutics goes public
4BIO portfolio company Orchard Therapeutics Announces $150 Million Series C Financing
Fellowship of the Royal Society elections
GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval